|
Market Closed -
Nasdaq
00:00:00 28/08/2026 +04
|
5-day change | 1st Jan Change | ||
| 0.6411 USD | +2.86% |
|
-7.10% | -59.42% |
| 08-28 | Outlook Therapeutics Appoints Kevin Lundquist as CFO | MT |
| 08-17 | EyePoint's drug for age-related eye disease fails late-stage trial, shares tank | RE |
Stock exchange
Nasdaq
OTLK 0.6411 $
+2.86%
4.37M
$
Quotes 5-day view: Outlook Therapeutics, Inc.
Delayed Quote Nasdaq
| 21/08/2026 | 24/08/2026 | 25/08/2026 | 26/08/2026 | 27/08/2026 | |
|---|---|---|---|---|---|
| Last | $0.6472 | $0.6090 | $0.6400 | $0.6233 | $0.6411 |
| Volume | 11,497,122 | 14,797,360 | 15,948,637 | 6,063,220 | 6,664,969 |
| Change | -4.30% | -5.90% | +5.09% | -2.61% | +2.86% |
| Opening | $0.6759 | $0.6223 | $0.6150 | $0.6400 | $0.6430 |
| High | $0.7060 | $0.6405 | $0.6847 | $0.6589 | $0.6750 |
| Low | $0.6400 | $0.5900 | $0.6115 | $0.6231 | $0.6355 |
Performance
| 1 day | +2.86% | ||
| 1 week | -7.10% | ||
| Current month | -34.35% | ||
| 1 month | -54.37% | ||
| 3 months | +60.19% | ||
| 6 months | +47.96% | ||
| Current year | -59.42% | ||
| 1 year | -76.26% | ||
| 3 years | -97.24% | ||
| 5 years | -98.69% | ||
| 10 years | -99.90% |
Volumes
marketsDaily volume
6,818,935
Estimated daily volume
6,818,935
Avg. Volume 20 sessions
27,906,491
Daily volume ratio
0.24
Avg. Volume 20 sessions USD
17,890,851.38
Record volume 1
346,266,295
Record volume 2
107,389,755
Record volume 3
104,623,239
Capital turnover ratio
0.11
Float rotation
0.13
Basic data
Market Cap (USD)
151,740,860
Net sales (USD)
1,413,000
Number of employees
17
Sales / Employee (USD)
83,118
Free-Float
86.07 %
Free-Float capitalization (USD)
130,605,511
Average Daily Capital Traded
11.79%
Indicators
Moving average 5 days
0.6392
Moving average 20 days
0.8786
Moving average 50 days
1.252
Moving average 100 days
0.8348
Price spread / (MMA5)
-0.30%
Price spread / (MMA20)
+37.05%
Price spread / (MMA50)
+95.30%
Price spread / (MMA100)
+30.21%
STIM
RSI 9 days
29.24
RSI 14 days
33.2
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.86% | -7.10% | -76.26% | -97.24% | 152M | |
| +0.10% | +1.59% | +1.76% | +24.32% | 50.96B | |
| +2.65% | +3.02% | +493.29% | +567.32% | 46.18B | |
| -0.88% | -1.16% | +20.58% | +87.74% | 42.73B | |
| +0.33% | +5.26% | +39.74% | +19.80% | 43.04B | |
| -2.27% | -3.02% | +14.22% | +51.50% | 33.48B | |
| -1.21% | +0.54% | +30.32% | +135.38% | 17.28B | |
| -0.36% | -3.95% | - | - | 16.43B | |
| +0.25% | +3.31% | +11.38% | +30.68% | 14.73B | |
| +0.44% | +2.21% | +81.06% | +47.92% | 14.09B | |
| Average | -0.01% | +0.23% | +68.46% | +96.38% | 27.91B | |
| Weighted average by Cap. | -0.29% | +1.15% | +105.68% | +141.69% |
Historical Quotes: Outlook Therapeutics, Inc.
| Date | Opening | High | Low | Close | Volume | Change |
|---|
Latest transactions
d31dfdd3dec10820bfe02237e7a22f.PVf8RKvRo-5huoaSd3GcpuzuXAuCpfqGrRQT59XV1CA.eC-PdOy9zLkJ78_YE1zX7o2vKDjn6LDw2k5M0qzim2tKP5AF6afyvDT7tg
| Date | Price | Volume | Total |
|---|---|---|---|
| 00:00:00 | 0.6411 | 41,961 | 6,340,488 |
| 23:59:59 | 0.6410 | 200 | 6,298,527 |
| 23:59:59 | 0.6359 | 300 | 6,298,327 |
| 23:59:59 | 0.6359 | 100 | 6,298,027 |
| 23:59:59 | 0.6396 | 4,700 | 6,297,927 |
| 23:59:59 | 0.6359 | 100 | 6,293,227 |
| 23:59:59 | 0.6359 | 400 | 6,293,127 |
| 23:59:59 | 0.6359 | 2,500 | 6,292,727 |
| 23:59:59 | 0.6371 | 200 | 6,290,227 |
| 23:59:59 | 0.6370 | 100 | 6,290,027 |
Price Extremes
| 1 week | 0.59 |  | 0.71 |
| 1 month | 0.59 | | 1.18 |
| Current year | 0.16 | | 1.88 |
| 1 year | 0.16 | | 2.54 |
| 3 years | 0.16 | | 29.2 |
| 5 years | 0.16 | | 57.3 |
| 10 years | 0.16 | | 878.4 |
Monthly variations
Annual variations
| 2026 | -59.42% | ||
| 2025 | -16.40% | ||
| 2024 | -76.02% | ||
| 2023 | -63.52% | ||
| 2022 | -20.59% | ||
| 2021 | +4.62% | ||
| 2020 | +120.34% | ||
| 2019 | -85.25% | ||
| 2018 | -61.54% | ||
| 2017 | -56.81% | ||
| 2016 | -29.51% |
- Stock Market
- Stocks
- OTLK Stock
- Quotes Outlook Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
